medigraphic.com
Colegio de Medicina Interna de México.

2006, Number 2

<< Back Next >>

Med Int Mex 2006; 22 (2)

Antiphospholipid syndrome. A report of a case and literature review

Etulain GJE, Arcos ZM, Villalobos SJA, Tanur TB, Aguirre SJ, Martínez SJ

Language: Spanish
References: 31
Page: 149-160
PDF size: 289.09 Kb.


ABSTRACT

Antiphospholipid syndrome is divided into primary (without clinical and biological manifestations of another disease) and secondary (related to other diseases, such as systemic lupus erythematosus, and other autoimmune affections). Some prospective studies have demonstrated relation between anticardiolipin antibodies and the first event of venous thrombosis, the first myocardial infarction and the recurrent cerebral vascular accidents. This paper presents the case of a woman with familial data of cerebral vascular event and diabetes mellitus 2, who received the diagnosis of antiphospholipid syndrome.


REFERENCES

  1. Ginsburg KS, Liang MH, Newcomer L, et al. Anticardiolipin antibodies and the risk for ischemic stroke and venous thrombosis. Ann Intern Med 1992;117:997-1002.

  2. Khamashta MA, Cuadrado MJ, Mujic F, Taub NA, et al. The management of thrombosis in the antiphospholipid-antibody syndrome. N Engl J Med 1995;332:993-7.

  3. Meroni PL, Raschi E, Camera M, et al. Endothelial activation by aPL: a potential pathogenetic mechanism for the clinical manifestations of the syndrome. J Autoimmun 2000;15:237-40.

  4. Hörkkö S, Miller E, Dudl E, et al. Antiphospholipid antibodies are directed against epitopes of oxidized phospholipids: recognition of cardiolipin by monoclonal antibodies to epitopes of oxidized low density lipoprotein. J Clin Invest 1996;98:815-25.

  5. Tincani A, Balestrieri G, Allegri F, et al. Overview on anticardiolipin ELISA standardization. J Autoimmun 2000;15:195-7.

  6. Levine JS, Subang R, Koh JS, Rauch J. Induction of anti-phospholipid autoantibodies by B2-glycoprotein I bound to apoptotic thymocytes. J Autoimmun 1999;12:143.

  7. Barreiro García G, Egurbide Arberas MV, Álvarez Blanco A, Ugalde Espineira J, Aguirre Errasti C. Acute adrenal insufficiency caused by bilateral adrenal hemorrhage as first manifestation of antiphospholipid syndrome. Report of a case and review. An Med Interna 2002;19:19-22.

  8. Nayak AK, Komatireddy G. Cardiac manifestations of the antiphospholipid antibody syndrome: a review. Mo Med 2002;99:171-8.

  9. Keswani SC, Chauhan N. Antiphospholipid syndrome. J R Soc Med 2002;95:336-42.

  10. Espinosa G, Cervera R, Font J, Asherson RA. The lung in the antiphospholipid syndrome. Ann Rheum Dis 2002;61:195-8.

  11. Isom R, Nickolas TL, Radhakrishnan J. Nephrological and obstetric complications of the antiphospholipid syndrome. Expert Opin Investig Drugs 2002;11:819-29.

  12. Oshiro BT, Silver RM, Scott JR, Yu H, Branch DW. Antiphospholipid antibodies and fetal death. Obstet Gynecol 1996;87:489-93.

  13. Pattison NS, Chamley LW, Birdsall M, Zanderigo AM, et al. Does aspirin have a role in improving pregnancy outcomes for women with the antiphospholipid syndrome? A randomized controlled trial. Am J Obstet Gynecol 2000;183:1008-12.

  14. Clifford K, Rai R, Watson H, Regan L. An informative protocol for the investigation of recurrent miscarriage: preliminary experience of 500 consecutive cases. Hum Reprod 1994;9:1328-32.

  15. Rand JH, Wu X-X, Andree HAM, et al. Pregnancy loss in the antiphospholipid- antibody syndrome. A possible thrombogenic mechanism. N Engl J Med 1997;337:1327.

  16. Di Simone N, Meroni PL, del Papa N, et al. Antiphospholipid antibodies affect trophoblast gonadotropin secretion and invasiveness by binding directly and through adhered beta2-glycoprotein I. Arthritis Rheum 2000;43:140-50.

  17. De Groot PG, Dersen RHWN. Specificity and clinical relevance of lupus anticoagulant. Vessels 1995;1:22-26.

  18. Viard JP, Amoura Z, Bach JF. Association of anti-beta2 glycoprotein I antibodies with lupus-type circulating anticoagulant and thrombosis in systemic lupus erythematosus. Am J Med 1992;93:181-6.

  19. Carreras LO, Forastiero RR, Martinuzzo ME. Which are the best biological markers of the antiphospholipid syndrome? J Autoimmun 2000;15:163-72.

  20. Harris EN, Peirangeli SS, Gharavi AE. Antiphospholipid syndrome: diagnosis, pathogenesis, and management. J Med Assoc Ga 2002;91:31-34.

  21. Wilson WA, Gharavi AE, Koike T, et al. International consensus statement on preliminary classification criteria for definite antiphospholipid syndrome: report of an international workshop. Arthritis Rheum 1999;42:1309-11.

  22. Asherson RA. Antiphospholipid antibodies and syndrome. In: Lahita RG, editor. Systemic lupus erythematosus. 2nd ed. New York: Churchill Livingstone, 1992;pp:587-635.

  23. Robey RA. Treatment of the antiphospholipid syndrome. Curr Opin Rheumatol 2002;14:238-42.

  24. Derksen RH, de Groot PG, Kater L, Nieuwenhuis HK. Patients with antiphospholipid antibodies and venous thrombosis should receive long term anticoagulant treatment. Ann Rheum Dis 1993;52:689-92.

  25. Prandoni P, Simioni P, Girolani A. Antiphospholipid antibodies, recurrent thromboembolism, and intensity of warfarina anticoagulation. Thromb Haemost 1996;75:859.

  26. Moll S, Ortel TL. Monitoring warfarin therapy in patients with lupus anticoagulants. Ann Intern Med 1997;127:177-85.

  27. Empson M, Lassere M, Craig JC, Scott JR. Recurrent pregnancy loss with antiphospholipid antibody: a systematic review of therapeutic trials. Obstet Gynecol 2002;99:135-44.

  28. Sullivan A, Branch DW. Can you manage antiphospholipid syndrome during pregnancy? Cont Obstet Gynecol 2001;46:100-22.

  29. Ginsberg JS, Greer I, Hirsh J. Use of antithrombotic agents during pregnancy. Chest 2001;119:122S-31S.

  30. Management of recurrent pregnancy loss. ACOG practice bulletin. No. 24. Washington: American College of Obstetrician and Gynecologist, 2001.

  31. Asherson RA, Cervera R, Piette J-C, et al. Catastrophic antiphospholipid syndrome: clinical and laboratory features of 50 patients. Medicine (Baltimore) 1998;77:195-200.




2020     |     www.medigraphic.com